The most outstanding
Grupo SURA signs Memorandum of Understanding with Grupo Argos for the evolution of their mutual holdings
Publicado el 25 October 2024
Grupo SURA is improving its share price conditions with the help of a new liquidity builder program
Publicado el 10 October 2024
News Center
Construction begins on VaxThera plant to produce vaccines and biologicals for Colombia and the rest of the region
Publicado el 02 February 2022
Country Code Survey*
Publicado el 31 January 2022
Board Decisions*
Publicado el 27 January 2022
Grupo SURA advances with the payment of dividends 2022
Publicado el 03 January 2022
Clarification on the acceptance percentages corresponding to the tender offer for Grupo SURA shares*
Publicado el 30 December 2021
Colombia signs an agreement governing the co -development of vaccines using mRNA technology
Publicado el 16 December 2021